News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,251 Results
Type
Article (28830)
Company Profile (349)
Press Release (453072)
Multimedia
Podcasts (69)
Webinars (11)
Section
Business (135595)
Career Advice (422)
Deals (24559)
Drug Delivery (76)
Drug Development (66456)
Employer Resources (66)
FDA (12204)
Job Trends (9931)
News (237917)
Policy (19230)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (1820)
Academic (1)
Accelerated approval (4)
Adcomms (17)
Allergies (68)
Alliances (36990)
ALS (79)
Alzheimer's disease (1232)
Antibody-drug conjugate (ADC) (128)
Approvals (12234)
Artificial intelligence (219)
Autoimmune disease (21)
Automation (11)
Bankruptcy (177)
Best Places to Work (8466)
BIOSECURE Act (15)
Biosimilars (81)
Biotechnology (262)
Bladder cancer (68)
Brain cancer (23)
Breast cancer (245)
Cancer (2026)
Cardiovascular disease (172)
Career advice (373)
Career pathing (10)
CAR-T (145)
Cell therapy (413)
Cervical cancer (16)
Clinical research (54323)
Collaboration (802)
Compensation (377)
Complete response letters (19)
COVID-19 (1995)
CRISPR (42)
C-suite (222)
Cystic fibrosis (90)
Data (1998)
Denatured (27)
Depression (43)
Diabetes (241)
Diagnostics (4866)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (19)
Drug discovery (108)
Drug pricing (47)
Drug shortages (16)
Duchenne muscular dystrophy (92)
Earnings (50642)
Editorial (26)
Employer branding (12)
Employer resources (60)
Events (81671)
Executive appointments (658)
FDA (13283)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (678)
Gene editing (105)
Generative AI (20)
Gene therapy (306)
GLP-1 (628)
Government (2428)
Grass and pollen (6)
Guidances (40)
Healthcare (12777)
Huntington's disease (22)
IgA nephropathy (30)
Immunology and inflammation (107)
Indications (28)
Infectious disease (2109)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (38)
Intellectual property (87)
Interviews (50)
IPO (12051)
IRA (20)
Job creations (1929)
Job search strategy (343)
Kidney cancer (9)
Labor market (12)
Layoffs (324)
Leadership (8)
Legal (3234)
Liver cancer (61)
Lung cancer (287)
Lymphoma (139)
Machine learning (6)
Management (16)
Manufacturing (257)
MASH (63)
Medical device (9005)
Medtech (9009)
Mergers & acquisitions (13036)
Metabolic disorders (598)
Multiple sclerosis (76)
NASH (17)
Neurodegenerative disease (86)
Neuropsychiatric disorders (28)
Neuroscience (1731)
NextGen: Class of 2025 (3677)
Non-profit (2665)
Northern California (2239)
Now hiring (27)
Obesity (303)
Opinion (143)
Ovarian cancer (68)
Pain (64)
Pancreatic cancer (75)
Parkinson's disease (139)
Partnered (17)
Patents (181)
Patient recruitment (107)
Peanut (42)
People (42335)
Pharmaceutical (68)
Pharmacy benefit managers (6)
Phase I (17312)
Phase II (23906)
Phase III (18012)
Pipeline (1078)
Policy (81)
Postmarket research (1830)
Preclinical (7192)
Press Release (60)
Prostate cancer (97)
Psychedelics (37)
Radiopharmaceuticals (245)
Rare diseases (362)
Real estate (3661)
Recruiting (27)
Regulatory (15263)
Reports (22)
Research institute (1845)
Resumes & cover letters (46)
Rett syndrome (5)
RNA editing (5)
RSV (26)
Schizophrenia (67)
Series A (126)
Series B (77)
Service/supplier (6)
Sickle cell disease (55)
Southern California (1943)
Special edition (12)
Spinal muscular atrophy (138)
Sponsored (27)
Startups (2670)
State (1)
Stomach cancer (10)
Supply chain (56)
Tariffs (17)
The Weekly (41)
United States (19127)
Vaccines (529)
Venture capitalists (35)
Weight loss (191)
Women's health (28)
Worklife (2)
Date
Today (177)
Last 7 days (732)
Last 30 days (2307)
Last 365 days (28446)
2025 (9006)
2024 (30157)
2023 (33607)
2022 (43710)
2021 (46640)
2020 (42593)
2019 (32186)
2018 (24094)
2017 (24507)
2016 (22908)
2015 (26833)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (438)
Alabama (48)
Alaska (4)
Arizona (120)
Arkansas (11)
Asia (30777)
Australia (5349)
California (5134)
Canada (1630)
China (500)
Colorado (224)
Connecticut (217)
Delaware (131)
Europe (69472)
Florida (690)
Georgia (184)
Hawaii (1)
Idaho (35)
Illinois (386)
India (26)
Indiana (267)
Iowa (7)
Japan (151)
Kansas (83)
Kentucky (11)
Louisiana (5)
Maine (36)
Maryland (703)
Massachusetts (4096)
Michigan (206)
Minnesota (280)
Mississippi (2)
Missouri (66)
Montana (27)
Nebraska (12)
Nevada (39)
New Hampshire (54)
New Jersey (1505)
New Mexico (25)
New York (1444)
North Carolina (811)
North Dakota (8)
Northern California (2239)
Ohio (157)
Oklahoma (13)
Oregon (28)
Pennsylvania (1114)
Puerto Rico (12)
Rhode Island (25)
South America (633)
South Carolina (8)
Southern California (1943)
Tennessee (68)
Texas (667)
Utah (107)
Virginia (122)
Washington D.C. (47)
Washington State (466)
West Virginia (1)
Wisconsin (39)
482,251 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Phase III
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a chronic blood cancer taking the drug didn’t need to have their blood removed to bring down dangerously high hemocrit levels.
March 3, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s Disease
February 19, 2025
·
4 min read
Cardiovascular disease
Mineralys’ Hypertension Drug Drops Blood Pressure in Phase II/III, Setting Up Market Clash
Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in a pair of clinical trials.
March 10, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Press Releases
Merck Exercised the Option for the Global Rights of Abbisko Therapeutics’s Pimicotinib
April 1, 2025
·
2 min read
Press Releases
Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities
April 23, 2025
·
5 min read
Press Releases
PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics
April 10, 2025
·
5 min read
Press Releases
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer
April 17, 2025
·
2 min read
Press Releases
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
January 29, 2025
·
5 min read
Press Releases
Garuda Therapeutics Closes $50 Million Series A-1 Financing to Advance Off-the-Shelf Blood Stem Cell Therapies
March 4, 2025
·
2 min read
1 of 48,226
Next
